0001209191-21-005768.txt : 20210127
0001209191-21-005768.hdr.sgml : 20210127
20210127201624
ACCESSION NUMBER: 0001209191-21-005768
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201204
FILED AS OF DATE: 20210127
DATE AS OF CHANGE: 20210127
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PAPADOPOULOS STELIOS
CENTRAL INDEX KEY: 0001202098
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35670
FILM NUMBER: 21561612
MAIL ADDRESS:
STREET 1: 3 SOMERSET DRIVE SOUTH
CITY: GREAT NECK
STATE: NY
ZIP: 11020
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Regulus Therapeutics Inc.
CENTRAL INDEX KEY: 0001505512
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264738379
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10628 SCIENCE CENTER DRIVE
STREET 2: SUITE 225
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-202-6300
MAIL ADDRESS:
STREET 1: 10628 SCIENCE CENTER DRIVE
STREET 2: SUITE 225
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2020-12-04
2020-12-07
0
0001505512
Regulus Therapeutics Inc.
RGLS
0001202098
PAPADOPOULOS STELIOS
C/O REGULUS THERAPEUTICS INC.
10628 SCIENCE CENTER DR., #225
SAN DIEGO
CA
92121
1
0
0
0
Common Stock
2020-12-04
4
A
0
793528
0.6301
A
2839707
D
This Form 4 is being amended to correct the number of securities beneficially owned following the reported transaction.
/s/ Christopher Aker, Attorney in Fact
2021-01-28